Centers for Disease Control and Prevention clinical trials
Listed in the registry as: U.S. federal agency.
The registry lists 275 studies whose lead sponsor is Centers for Disease Control and Prevention. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 21, 2026.
Keep track of what changes. Save the Centers for Disease Control and Prevention studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Centers for Disease Control and Prevention leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 275. Browse all 275 →
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBIRecruitingNCT03474029Phase 2/3
- The National Amyotrophic Lateral Sclerosis RegistryRecruitingNCT01772602
- Short-course Regimens for the Treatment of Pulmonary TuberculosisActive, not recruitingNCT05766267Phase 2/3
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of TuberculosisCompletedNCT02563327Phase 3
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) TreatmentCompletedNCT00694629Phase 2
- Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 YearsCompletedNCT05514002Phase 4
- Tuberculosis Clinical Trials Consortium Study 35CompletedNCT03730181Phase 1/2
- TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB InfectionCompletedNCT00164450Not applicable
- TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TBCompletedNCT00664313Phase 1/2
- An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB TreatmentCompletedNCT03266003Not applicable
- Study of Intradermal Administration of PCEC Rabies VaccineCompletedNCT01044199Not applicable
- A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in HumansCompletedNCT01243437Phase 2
- Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaCompletedNCT00164281Phase 4
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy AdultsCompletedNCT06485258Phase 1
- Bismuth Subsalicylate's Role in the Prevention of Travelers' DiarrheaTerminatedNCT03535272Phase 3
- Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCPCompletedNCT06054269Phase 3
- Problem Solving for Caregivers of Persons With Brain InjuryWithdrawnNCT00164645Not applicable
- Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority AdolescentsCompletedNCT00137644Phase 1/2
- Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy TrialCompletedNCT00448981Not applicable
- Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIVTerminatedNCT06045923
- JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the CongoCompletedNCT02977715Phase 3
- CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy AdultsActive, not recruitingNCT06962904Phase 1
- A Waiting Room-Delivered Video to Enhance Clinical Outcomes Among Persons Living With HIVCompletedNCT03508310Not applicable
- Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of AgeCompletedNCT03071575Phase 4
- Brief, Behavioral Intervention to Reduce Douching Among Adolescent and Young WomenCompletedNCT00207480Not applicable
- Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young ChildrenCompletedNCT06938620Not applicable
- Chlorproguanil-Dapsone in Pregnant WomenTerminatedNCT00126971Phase 1
- Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 VirusesWithdrawnNCT00417560Not applicable
- Brief Intervention to Increase Safety Belt Use Among ED PatientsWithdrawnNCT00300859Phase 4
- A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During BreastfeedingCompletedNCT00146380Phase 2
- Optimizing Strategies to Improve STD Partner ServicesCompletedNCT00207454Phase 1
- Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months OldCompletedNCT03725618Phase 4
- Impact on Linkage to HIV Care With Point of Care CD4 Testing and Home-based HIV Testing in KenyaCompletedNCT02515149Not applicable
- HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV TransmissionCompletedNCT02044484Not applicable
- Dane County Safety Assessment (SAFE) Research StudyCompletedNCT00140322Not applicable
- Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus VaccineCompletedNCT05460377Phase 4
- Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOTCompletedNCT01582711Phase 3
- Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer ScreeningCompletedNCT00207636Not applicable
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening RegimensCompletedNCT02410772Phase 3
- Health Promotion of People With DisabilitiesCompletedNCT00164489Phase 2/3
- Immunogenicity nOPV2 With and Without bOPVCompletedNCT04579510Phase 2
- Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native EldersCompletedNCT00153543Phase 1
- Immunogenicity of Influenza Vaccines in HIV-infected Persons in ThailandCompletedNCT01538940Phase 4
- Household Influenza Transmission StudyCompletedNCT01251679Not applicable
- Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis InfectionCompletedNCT00023452Phase 3
- A Methadone Maintenance Treatment Outcome Study in Three Provinces in ChinaCompletedNCT01315054Not applicable
- Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young ChildrenCompletedNCT00139113Phase 4
- Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessCompletedNCT00127504Phase 2
- The California WISEWOMAN Project:Cardiovascular(CVD) Health for Hispanic WomenCompletedNCT00153400Not applicable
- West Virginia WISEWOMAN Pilot Study to Test a Brief Nutrition InterventionCompletedNCT00153413Not applicable